spacer
home > ict > autumn 2009 > different countries, different approaches
PUBLICATIONS
International Clinical Trials

Different Countries, Different Approaches

 

Since the establishment of ICH-GCP, the globalisation of clinical trials has proven to be an irreversible trend. Pharmaceutical and biotechnology companies (mainly through CROs) are increasingly testing their candidate drugs in Latin America, eastern Europe and in the Asia-Pacific region. Each of these regions is composed of many different countries, each with their own clinical research regulations.

From an operational standpoint, it is not very difficult to reconcile the differences of clinical practices around the globe, although there are particularities. The operational implementation of a clinical protocol is basically the same from one place to another, and it is possible to conduct a global multi-centric study while maintaining the quality of the generated data.

From a legal standpoint, this same globalisation scenario can be slightly different. Legal systems may have a number of similarities, but unlike the ethical and operational aspects, legal differences are harder to standardise and globalise.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Vitor Harada is a Clinical Development professional with 11 years of experience. He graduated in Pharmacy and Biochemistry from the University of São Paulo (USP) and has a MBA from the Fundação Getulio Vargas (FGV). Vitor is currently a Director of Clinical Operations at ICON and responsible for the company’s office in Brazil. He is also President of ABRACRO (Brazilian Association of CROs) and one of the Professors/Coordinators of the Clinical Research Postgraduation Course of the Santa Casa de São Paulo Medical School. In the past, Vitor has worked for AstraZeneca (where he was the local Head of the Clinical Department), Pharmacia and Bristol-Myers Squibb.
spacer
Vitor Harada
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

MedPharm’s CSO and University of Reading Professor co-author new book on dermal formulation development

MedPharm’s Chief Scientific Officer and Co-Founder, Professor Marc Brown and University of Reading’s Professor Adrian Williams have co-authored the new book: ‘The Art and Science of Dermal Formulation Development”. It is the latest addition to ‘Drugs and the Pharmaceutical Sciences’, a series of textbooks and monographs published by CRC Press.
More info >>

White Papers

Clinical Trials in Ukraine: Orange Paper Overview and 1st Half Year 2014

Synergy Research Group

The Orange Paper is an analytical report about the clinical trials market in Russia, published quarterly by the contract research organization Synergy Research Group. The first edition of Orange Paper was released in 2006, and at the moment 31 issues have already published. Now, thanks to Synergy Group Ukraine, obtaining information about the market of clinical trials in Ukraine has become possible. In Ukraine, during the period from 1996 to 2013, applicants had obtained 3,864 positive conclusions about the possibility of conducting clinical trials of drugs, both for domestic and foreign manufacturers, including conduct of multinational multi-center clinical trials (hereinafter – MMCTs)
More info >>

 
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement